Concepedia

Ken Schooley

KS

14

Publications

6.2K

Citations

14

H-Index

1989

Active since

Affiliations

Research & Development Corporation(Current)

Amgen (United States)

Institut Gustave Roussy

IDEX Corporation (United States)

Inserm

Ken Schooley is an author at Research & Development Corporation specializing in medicine, cell biology, and immunology.

Top concepts

MedicineImmunologyCell BiologyCell SignalingAutoimmunityInflammationImmunotherapyApoptosisCell DeathAutoimmune Disease

Publications per year

1989–2011

14

Publications

14

Identification and characterization of a new member of the TNF family that induces apoptosis

Steven R. Wiley, Ken Schooley, Pamela J. Smolak et al. · Immunity · 1995 · 2.9K citations · Full text

Inflammation, Cytokine, Signaling Pathway +12

Fas ligand mediates activation-induced cell death in human T lymphocytes.

Mark R. Alderson, Teresa W. Tough, Terri Davis‐Smith et al. · The Journal of Experimental Medicine · 1995 · 944 citations · Full text

Fas-positive Target Cells, T-regulatory Cell, Apoptosis +17

Fas transduces activation signals in normal human T lymphocytes.

Mark R. Alderson, Richard J. Armitage, Eugene Maraskovsky et al. · The Journal of Experimental Medicine · 1993 · 518 citations · Full text

Lymphocyte Development, Apoptosis, Immunology +16

Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail)

Neil A. Fanger, Charles R. Maliszewski, Ken Schooley et al. · The Journal of Experimental Medicine · 1999 · 408 citations · Full text

The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39.

Aaron J. Marcus, M. Johan Broekman, Joan H.F. Drosopoulos et al. · Journal of Clinical Investigation · 1997 · 407 citations · Full text

Platelet Function, Endothelial Cell Ecto-adpase, Cellular Physiology +24

Rows per page

1–5 of 14